s -r y 1. To examine the role of angiotensin I1 in the maintenance of blood pressure and control of aldosterone secretion, eight normal human subjects were studied on a tilt table in sodium-replete and sodium-depleted states, before and after the administration of an angiotensin converting-enzyme inhibitor (CEI).
Introduction
The role of the renin-angiotensin system in the maintenance of normal blood pressure has been uncertain. The recent availability of effective competitive inhibitors of angiotensin-converting enzyme and of the action of angiotensin on its vascular receptors has permitted a critical examination of this question. Recent experiments in rats, rabbits and in trained, conscious dogs (Gavras, Brunner, Vaughan & Laragh, 1973; Samuels, Miller, Fray & Haber, 1973; Mimran, Guiod & Hollenberg, 1974) have demonstrated that angiotensin I1 is essential in the maintenance of normal blood pressure in the sodium-depleted but not in the sodium-replete animal. In the present experiments the role of renin in the maintenance of blood pressure and in the regulation of aldosterone in relation to posture is examined in normal man.
Methods

Human subjects
Eight normal subjects ranging in age from 19 to 27 years, including seven men and one woman, were studied. Subjects gave informed consent and the protocol of the investigation was approved by the institution's human studies committee.
Group 1. Four subjects were maintained for 3 days on a 110 mmol Na-100 mmol K diet. On the subsequent day, subjects remained supine on a tilt table for 30 min, were tilted upright to 70" for 30 min and then permitted to remain supine for an additional 30 min. Heart rate and blood pressure were monitored. Blood samples were obtained at frequent intervals.
A single injection of converting-enzyme inhibitor (25 pmollkg) was given intravenously 30 min after the first tilt and the earlier protocol was repeated. Subsequently, the subjects were either maintained on a 10 mmol Na-100 mmol K diet for 3 days (two subjects) or were given 80 mg of frusemide orally 12 h before the study. Their mean weight loss was 2.67 1.18 kg. The same experimental protocol as described above was then repeated.
Group 2. Four subjects were maintained first on a 110 mmol Na-100 mmol K diet for 5 days and then o n a 10 mmol Na-100 mmol K diet. Before the experiment, 24 h urine sodium excretion was 138 f 24 mmol on the high sodium diet and 15 1 11 mmol on the low-sodium diet. Average weight loss was 2.1 6 f 0.39 kg on sodium restriction. Each subject was studied on four separate experimental days, on 110 mmol Na diet, on 10 mmol Na diet, with and without CEI. In each study, after a supine equilibration period of 30 min, an injection of either CEI") (25 mmolikg) or diluent (placebo) was given. Fifteen minutes after the injection subjects were tilted to 70" for 7 rnin or until they felt faint.
Group 3. Five subjects were examined on a free diet and 12 h after the oral administration of 80 mg of frusemide (weight loss 1.54 f 0.37 kg). After a 30 rnin period of blood pressure equilibration in the supine position, 12.7 pmol of CEI or diluent was administered, followed by a continuous infusion of CEI (12.7 pmol/min) or diluent. At 150 rnin the subjects were tilted upright for 7 min or until they fainted. The subjects were studied during four experimental sessions on separate days on a free diet with and without CEI and subsequent to frusemide with and without converting-enzyme inhibitor.
Plasma bradykinin concentrations were measured in two subjects in group 1 before and 5, 30 and 60 rnin after CEI, and in one subject in group 3 before and 15 and 150 min after CEI.
Analytical techniques
Plasma renin activities (PRA) were assayed by methods previously described (Haber, Koerner, Page, Kliman & Purnode, 1969) . Plasma aldosterone determinations were done by a direct radioimmunoassay on plasma extract (Poulsen, Vetter, Sancho & Haber, 1974) . Plasma bradykinin was determined by the method of Talamo, Haber & Austin (1969).
Converting-enzyme inhibitor
The converting-enzyme inhibitor utilized was the ( l ) Abbreviations: CEI, converting-enzyme inhibitor; PRA, plasma renin activity. nonapeptide originally isolated from Bothrips venom having the sequence Tyr-Trp-Pro-Arg-ProGln-Ile-Pro-Pro. Early experiments were performed with samples of this material kindly donated by Squibb (SQ 20,881). Later experiments were carried out with peptide synthesized in our laboratory, utilizing solid-phase synthetic techniques.
Results
Group 1
As is apparent from examination of Table I , sodium-replete subjects underwent a modest narrowing of pulse pressure associated with tachycardia after 2 min of tilting. Identical changes on tilting were observed after administration of CEI, indicating that CEI did not have an effect on the haemodynamic response to tilting in the sodiumreplete subject. After sodium depletion, these haemodynamic changes were exaggerated. After the administration of CEI in the sodium-depleted subject tilting resulted in a dramatic and significant fall in blood pressure (P<0.05) accompanied by a marked tachycardia.
The sodium-replete subjects showed a significant rise in PRA (P<0.05) and plasma aldosterone (P<O.Ol) during tilting. After CEI, PRA rose significantly higher on tilting (P<0.05), though there was no rise in plasma aldosterone. Sodium-depleted subjects had more dramatic rises in PRA and plasma aldosterone during control tilting studies. PRA was still further elevated on the tilt after CEI, though plasma aldosterone concentrations fell to base-line. These studies indicate that CEI administration results in a marked augmentation of the response of PRA to tilting, while completely blocking the response of plasma aldosterone.
Group 2
In order to exclude effects of diuresis independent of sodium depletion, haemodynamic studies were carried out in an additional group of four subjects who were sodium-depleted by diet alone. In this group, each tilting experiment was carried out on a separate day to exclude the effects of one experiment on a subsequent one. Table 1 confirms the haemodynamic observations made in group 1 . Sodiumdepleted subjects had a significantly greater fall in blood pressure (P<0.05) on tilting after CEI than did sodium-replete subjects. PRA (ng h-' ml-') Plasma aldosterone (pglrnl)
Group 3
In order to examine the persistence of the haemodynamic and hormonal effects of CEI, an infusion of CEI was continued for 150 min and subjects were tilted at the end of that period. Results in Table 1 confirm observations made in group 1 and group 2 at shorter intervals. As shown in the previous groups, there is no significant difference in upright blood pressure or heart rate in sodium-replete subjects before and after CEI. However, in sodium-depleted subjects a dramatic fall in blood pressure (P<0.05) was again observed on tilting after CEI administration. In the sodium-depleted subjects supine PRA was significantly higher than in control subjects after CEI (P<0.02), whereas plasma aldosterone concentrations were significantly lower (P<O.Ol). These results indicate that the dissociation of PRA and aldosterone seen on tilting in group 1 in response to CEI could also be observed in the supine position in group 3, suggesting that the rise in aldosterone in response to sodium depletion is also blocked by CEI.
No rise in bradykinin concentration was observed in any of the samples analysed.
Discussion
CEI previously has been demonstrated to block conversion of angiotensin 1 into 11 in man at doses similar to those used in this study (Collier, Robinson & Vane, 1973) . Because of the short half-life of angiotensin 11, within minutes after administration of CEI, the circulating amounts of this hormone should be negligible. From the data presented, it appears that angiotensin I1 is needed for the haemodynamic adjustment to upright tilting in sodiumdepleted man; in its absence the sympathetic nervous system and other homeostatic mechanisms are inadequate to maintain blood pressure. Appropriate adrenergic response to hypotension is indicated by the invariable tachycardia observed when blood pressure falls. In the sodium-replete individual, other homeostatic mechanisms appear sufficient. It is unlikely that the other effect of CEI, inhibition of bradykinin breakdown, is responsible for these observations since increase of plasma bradykinin concentration was not observed.
We have previously demonstrated that PRA rises rapidly on tilting (Oparil, Vassaux, Sanders & Haber, 1970) . The data in these experiments show that plasma aldosterone follows with similar kinetics.
CEI administration is associated with a significant increase in PRA in the supine position, more marked in sodium-depleted than in sodium-replete subjects at times when no significant haemodynamic change can be observed. This observation indicates that angiotensin I1 exerts negative feedback control on renin secretion.
After CEI administration, plasma aldosterone no longer follows the rise in PRA and remains either unchanged or falls either upon sodium depletion or tilting. These observations indicate that the major stimulus to aldosterone secretion in response to tilting or sodium depletion is angiotensin 11. The earlier suggestion that angiotensin I may stimulate aldosterone secretion in airro (Saruta, Cook & Kaplan, 1972) does not seem to be confirmed if7 i'ico.
